Biomarker-enhanced ED Disposition Decisions

CompletedOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions
Non-specific Complaints
Interventions
BIOLOGICAL

biomarker-enhanced disposition decision with proADM

To compare the outcome of standard of care with an approach combining the standardized course and biomarker levels (biomarker-enhanced disposition decision with proADM) for the disposition of patients with non-specific complaints presenting to the emergency department (ED), in order to evaluate safety.

Trial Locations (1)

4031

University Hospital Basel, Basel

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER

NCT00920491 - Biomarker-enhanced ED Disposition Decisions | Biotech Hunter | Biotech Hunter